Press Room
Announcements, joint venture milestones and the group's thinking on the sectors it operates in.
14 July 2026
Following the Gypto Alqalaa Pharma joint venture in Egypt, the group has formalised pharmaceutical manufacturing as a standalone core sector alongside infrastructure, industry, technology and essential services.
18 June 2026
The group has formed Q PERIFA with Australia's PERIFA Developments, the development arm of Versatile Group, to deliver end-to-end development management for large-scale land holdings.
5 June 2026
Sixty thousand square metres of the Gypto complex are dedicated to specialised high-technology therapies. Here is why that footprint matters more than its size suggests.
2 June 2026
Most land banks underperform not because of the land, but because of who controls the decisions. A short note on where value actually leaks.
21 May 2026
The group has entered a joint venture with Swiss and Luxembourg-based global steel trader Trasteel Holding S.A., extending its industrial footprint across MENA markets.
12 May 2026
What a global steel trader actually contributes to a regional joint venture — and why it is mostly not about price.
6 May 2026
Regional steel consumption remains anchored to committed national infrastructure programmes rather than to global cycle sentiment.
1 May 2026
Stockpiles expire. Supply chains reroute. The only durable form of medicine security is regional manufacturing capability.
22 April 2026
Where information and communication technology stops being an IT decision and becomes a matter of national capability.
17 March 2026
From its Abu Dhabi headquarters, the group maintains representative offices in Egypt, Germany, India and the United States.
24 February 2026
Treating waste as a logistics problem produces logistics returns. Treating it as infrastructure produces something more durable.
15 January 2026
Chairman Eissa Ateeq Almazrouei on capital horizons, national mandate and why the group measures itself in decades.
9 December 2025
Import dependence is not solved by buying more. It is solved by owning parts of the chain that can be redirected.
11 November 2025
Current Good Manufacturing Practice is often described as a certification. It is closer to an operating culture with paperwork attached.
8 April 2025
The group's first venture in the pharmaceutical sector, formed with Gypto Pharma to manufacture medicines across sterile and non-sterile streams in Egypt.
